VENKATA SUBRAHMANYAM KOLIPAKA

I am a driven graduate student at Northeastern University with a background in pharmacy and practical experience gained through internships and professional roles. My primary focus is on ensuring GMP compliance and managing batch disposition in pharmaceutical manufacturing. I have a strong understanding of Quality Assurance processes, including reviewing batch records, managing the disposition of raw materials and finished products, and ensuring that products meet regulatory and quality standards. My dedication to lifelong learning and staying up to date with industry regulations enables me to contribute to batch disposition, quality assurance, and GMP compliance efforts, ensuring that high-quality medicine reaches the market efficiently.on of successful products.

Environmental conservation, Theater, Cooking, Travel, Sports.

Northeastern University - Boston, MA, USA. Analysis of Sandoz's Omnitrope approval under 505(b)(2) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), Omnitrope (Somatropin recombinant DNA origin) Injection, manufactured by Sandoz Inc., was given FDA approval on May 30, 2006. Preclinical safety data would have most likely been reported for biosimilars like Omnitrope are Pharmacodynamic Studies and Pharmacokinetic Studies.,

 Andhra University – Visakhapatnam, AP, INDIA. Comparative Studies of Mesalamine Products in The Indian Market, Comparing mesalamine medicinal goods, such as tablets, on the Indian market to research the rates of dissolution and prices of certain brands, as well as documenting the dissolution rate and the time taken for the drug to disintegrate into particles to create a project.